Menu
  • Join
  • Login
  • Contact
 

FIP Covid-19 Information Hub

FIP guidance

FIP Guidance 
& summaries

 

FIP resources

Other
FIP
resources

 

Online programme

FIP COVID-19

Online Programme 
(webinars)


COVID-19 vaccinations

 

 

Resources from around the world

Resources from
organisations
around the world

 

pharmacy heroes campaign

#PharmacyHeroes 
Campaign
 

Questions

Questions from
FIP members


 

articles

Articles

 

FIP Timeline

FIP COVID-19 
Timeline

In memoriam

In memoriam

       

 

FIP Guidance on COVID-19

This guidance is based on the available evidence and the recommendations of reputable organisations such as the World Health Organization, the United States and the European Centres for Disease Control and Prevention, and others, at the time of publishing. Knowledge on COVID-19 is rapidly changing and recommendations may change accordingly. Although FIP will strive to keep these guidelines up to date, we recommend consulting the websites of these organisations and any newly available evidence for the most recent updates. Our guidance is divided into four sections. Guidance specifically for community, hospital and clinical biology sectors can be found in Section 2 “Guidelines for pharmacists and the pharmacy workforce”. The guidance is supplemented with summaries and it is accessible here.

 

Other FIP resources

 


FIP call to action to support pharmacists and pharmacy workers on the coronavirus/COVID-19 frontline 
This call to action is also available in ArabicChineseFrench, Greek, ItalianMontenegrin, PortugueseRussian, Serbian and Spanish. More translations to come.

 


COVID-19 vaccinations

Argentina: According to a report on 6 January 39,599 doses of Sputnik V have been administered to health care professionals.1,088 adverse events were registered, of which 97.7% were mild.

Australia: Pharmacies will begin to vaccinate in mid-2021, when the vaccination will be extended to groups of the general population (more here). The requirements for training and certifying pharmacists as vaccinators have been modified to allow the theoretical part of this training to be done online; also, the requirement for pharmacists to have a prior first-aid certificate is temporarily waived (more here). Starting around May, community pharmacies will be paid up to 48AUD (30EUR) to vaccinate patients. However, they need to ensure that they are able to continue to provide their regular important services to their local communities, Health Minister Greg Hunt has said, according to a report in The Sunday Telegraph in January. Australia began its mass COVID-19 vaccine programme in February and pharmacists were among the frontline healthcare staff receiving the first doses. Plans are for the population to be vaccinated by the end of October, with the majority to receive the AstraZeneca vaccine produced locally. In preparation for Australia’s vaccine rollout, the Australian Government has partnered with the Australian College of Nursing to develop accredited training modules, which are freely accessible to all authorised COVID-19 vaccination providers, including pharmacists. Australia’s policy for vaccinating the population against COVID-19 was updated last month. This states that pharmacists are licensed to varying degrees in each state and territory to administer vaccines and are likely to play a role in COVID-19 vaccination for “some part of the population (e.g. healthy adults) at some stage, depending on the safety profile of the vaccines”.

Brazil: In January, the country announced that it would manufacture the Russian vaccine Sputnik V, but that the entire production would be exported to other Latin American countries that had already approved the vaccine, including Argentina and Bolivia. Also in January, Reuters reported on a Brazilian study indicating that China’s Sinovac vaccine is 78% but experts have called for more transparency on the data.

Canada: The Canadian Pharmacists Association and Neighbourhood Pharmacies have issued recommendations on COVID-19 vaccines and pharmacy readiness. Roll out plans are being developed by provincial and territorial governments according to Canada’s 7-point COVID-19 Immunization Plan and NACI’s Recommendations for Use of Coronavirus Vaccines. Priority populations include seniors, healthcare workers, long-term care residents and indigenous communities. The overall goal is to receive enough COVID-19 vaccines to start vaccinating all Canadians by March and have 100% of the population vaccinated by December. However, it is still unclear what the responsibilities and activities of the pharmacy workforce will be, or what (if any) additional training may be required. More here

Europe: manifesto to encourage healthcare professionals to get vaccinated against COVID-19 was published on 9 February by the European Coalition for Vaccination.

France: The minister of health has said that the government will engage all health professions — including pharmacists — in mass vaccination when more vaccines are available, but there is not yet a published document on how this will be implemented, according to a report from the French Chamber of Pharmacists in January. On 2 February, the French National Health Authority issued an opinion in favour of COVID-19 vaccination by community pharmacists and midwives of people between the ages of 50 and 64 years with the AstraZeneca vaccine (more here).

Ireland: The Irish Government’s National COVID-19 Vaccination Strategy and Implementation Plan explicitly include community pharmacies alongside GPs as vaccine access locations. Below are three recent Statutory Instruments (i.e. Ministerial Regulations) that are relevant:

• S.I. No. 698 of 2020 allows COVID-19 vaccination by a range of persons including community pharmacists wherever deemed suitable and also covers records required;
• S.I. No. 1 of 2021 allows hospitals who do not hold wholesaler licences to supply COVID-19 vaccines to persons authorised to administer them, which would include community pharmacies;
• S.I. No. 2 of 2021 permits six doses of Comirnaty® (Pfizer) to be administered from each vial (instead of five)
Clinical Guidance for Covid‐19 Vaccination (6 January 2021)

Israel: A drop of 60% in hospital admissions after three weeks is the impact of a quick and efficient vaccination campaign (more here). Only 0.04% of people have caught the virus a week after the second vaccine dose and only 0.002% needed hospital treatment, according to data released by Israel’s health ministry (more here).

Italy: The region of Lombardy is the latest region that has agreed with health authorities that pharmacists should be able to carry out COVID-19 vaccinations, joining the region of Piedmont in January. The region of Lazio is expected to follow. It is envisaged that pharmacy-based vaccinations will cover people between 40 and 60 years of age and will begin at the end of March, when more vaccines which can be stored in pharmacy refrigerators are available, Federfarma reports. Meanwhile, Federfarma also reports that the first phase of vaccination aimed at health and social health personnel in the Emilia Romagna region was completed in February and around 370,000 people aged over 80 years are now receiving a letter, giving them the option to use an affiliated pharmacy (in addition to telephone and internet) to make a booking for their first and second doses. However, the region’s pharmacies are not yet providing a vaccines administration service.

Norway: The Ministry of Health has proposed legislative amendments to allow pharmacists to request COVID-19 vaccines, the Norwegian Pharmacy Association (NPA) reported in February. With this change, municipalities will have access to 2,000 more health personnel who may play a crucial role in increasing the pace when vaccines supplies increase. It is very positive that the Minister of Health is coming up with this initiative now, while there is still time to prepare for mass vaccination in the municipalities, said Per T. Lund, CEO of the NPA. 

Philippines: Pharmacists are included in the Philippine National Deployment and Vaccination Plan for COVID-19 Vaccines. Following a two-day training period, community pharmacists in the Philippines started administering COVID vaccines in February, the Philippine Pharmacists Association has reported. 

Portugal: Engagement of pharmacies is among solutions being looked into to increase vaccination capacity, according to the government’s newly appointed task force coordinator vice-admiral Henrique Gouveia e Melo. The rate of vaccination is currently around 22,000 vaccines per day but manufacturers meet the vaccine delivery schedule for quarter 2, the pace is expected to increase to around 80,000 vaccines per day. In response, Portuguese Pharmaceutical Society president, Ana Paula Martins, has reiterated the availability for community pharmacists to collaborate, under terms agreed with the Ministry of Health. “We will come to a time when we will have to vaccinate almost 200,000 people per day. In this context, I am very convinced that pharmacies will surely be able to reach up to 50,000 vaccines per day", she told the media in February. (more here).

South Africa: The Department of Health launched a campaign —“I choose vaccination because...” #VacciNation — in February to encourage all South Africans to get vaccinated against COVID-19. Pharmacists are among the health professionals around the country taking part in the campaign’s video messages

UK: The Adam Smith Institute published a position paper (4 January) calling for the acceleration of vaccination against COVID-19, and one of the main measures proposed is vaccination in pharmacies. Some community pharmacies will start administering vaccinations on 11 January (more here). The Tony Blair Insitute published "A blueprint for accelerated vaccine rollout" on 6 January.

USA: Vaccination in pharmacies, limited to priority groups, has started (more here). Vaccinations in geriatric care centres are largely carried out by pharmacists (more here). Meanwhile, President Joe Biden has advocated for the involvement of pharmacies and pharmacy-based vaccination in the context of COVID-19 (watch here) and using a network of local pharmacists has been held up as a shining example of a successful vaccination strategy in West Virginia in an NBC News report.

Resources from FIP members and others*

*Please note that this sharing of guidance and examples from our member organisations and others is not an endorsement of these materials and we can take no responsibility for their accuracy or their being up-to-date.

Africa

LiveWell Initiative: Guidance to support pharmacists in the African region in the management of COVID-19.

Argentina

Pharmaceutical Confederation of Argentina: "Protocolo COFA de actuación en la farmacia comunitaria ante la pandemia de coronavirus"

Asia

Federation of Asian Pharmaceutical Associations:

Australia

Australian Commission on Safety and Quality in Health Care

Medicines management in COVID-19 resources

Pharmaceutical Society of Australia:

Pharmacy Guild of Australia: Information and guidance for community pharmacies in Australia

University of Melbourne: The lessons from past pandemics

Austria

Austrian Pharmacists Chamber:  "Measures taken in the wake of the corona crisis concerning community pharmacies in Austria"

Belgium

Association Pharmaceutique Belge (APB): COVID-19 information website

Brazil

Brazilian Federal Council of Pharmacy:

Canada

Canadian Pharmacists Association:

China

Centre for Health Protection, Department of Health, Government of Hong Kong SAR: Severe respiratory disease associated with a novel infectious agent (information and resource centre) (Simplified Chinese)

Chinese Pharmaceutical Association:

  • Novel Coronavirus (COVID-19) outbreak prevention and control: Guidance and management strategies for pharmacists and the pharmacy workforce  Chinese    English
  • Expert consensus to guide the prevention and control of the COVID-19 epidemic for retail pharmacy staff Chinese    English
  • Hospital pharmacy professional committee expert consensus on rational drug use in clinical practice for COVID-19  Chinese    English

Zhejiang Hospital Pharmacy Administration & Quality Control Centre: Suggestions about diagnosis and treatment of novel coronavirus pneumonia in pharmacy work

Zhongnan Hospital of Wuhan University Protection strategies of pharmaceutical posts, pharmacists and logistics personnel in the context of novel coronavirus infection

China Taiwan

Taiwan Society of Health-System Pharmacists: Community Pharmacists in Taiwan at the Frontline Against the Novel Coronavirus Pandemic: Gatekeepers for the Rationing of Personal Protective Equipment"

Commonwealth of nations

Commonwealth Pharmacists Association: How to Manufacture Alcohol Hand Rub: Training video launched to support COVID-19 response

Costa Rica

College of Pharmacists of Costa Rica:

Ecuador

"COVID-19 guidance"

Egypt

"COVID-19: 10 step guidance for pharmacy teams"

Europe

European Association of Hospital Pharmacists: COVID-19 Resource Centre

European Centre for Disease Prevention and ControlNovel coronavirus

Pharmaceutical Group of European Union: COVID-19 Information Hub

France

"Advice for pharmacies"

French Chamber of Pharmacists:

COVID-19 Information for pharmacists

Ministère des Solidaritès et de la Santé: COVID-19 hub

The International Conference of French-speaking Chambers of Pharmacists (CIOPF):

COVID-19 News, resources and information

 

Germany

Federal Union of German Associations of Pharmacists:

Greece

Ministry of Health Greece: Instructions for protection against respiratory infection from the new coronavirus

Panhellenic Association of Pharmacists (PEPharm): COVID-19

National Pubic Health Organization: New Covid-19 corona - Instructions

Italy 

Federfarma

Japan

The Pharmaceutical Society of Japan: COVID-19 News

Lebanon

Ministry of public healthGuide to avoid coronavirus infection

Malaysia

"COVID-19 pandemic guidance document for Malaysian pharmacists"  English    Malaysian

Nepal

Nepal Pharmaceutical Association: COVID-19 Guideline for pharmacists and pharmacy assistant

Netherlands

The Royal Dutch Pharmacists Association 

  • The National Institute for Public Health and the Environment (RIVM) has published a report about care during the COVID-19 pandemic (pp54-8 talk about pharmaceutical care). An abstract in English is available here.
  • COVID-19 hub in The Netherlands
  • Pharmacists can publish their best practices and efforts about pharmaceutical care in the period of COVID-19 here.
  • Thank you message to pharmacists.

The Dutch Minister of Health recognizes the role of Dutch pharmacists in a letter addressed to The Royal Dutch Pharmacists Association and in a message addressed to Dutch Parliament.

Pakistan

COVID-19. Ten steps guidance for pharmacy teams. English  Arabic.

Philippines

Philippine Pharmacists Association: Community Pharmacy Guide COVID-19 Preparedness

Portugal

Actions against COVID (Portuguese Pharmaceutical SocietyPortuguese Pharmaceutical Society and National Association of Pharmacies of Portugal)

Portuguese Pharmaceutical Society:

National Association of Pharmacies of Portugal:

Pharmacy's response to COVID-19: A virtual exhibition. How to participate? Watch this interview to Joao Neto, curator, Pharmacy Museum of the National Association of Pharmacies of Portugal.

"Boas Practicas e estrategias a adopter pelas farmacias"

ANF Thank you pharmacies video

APFH - Associação Portuguesa de Farmacêuticos Hospitalares

Hospital pharmacy recommendations

Serbia

Pharmaceutical Chamber of Serbia

"КОРОНА ВИРУС SARS-CoV-2 Информације и привремене смернице за фармацеуте и апотекарску делатност"

Slovenia

University of Ljubljana

"COVID-19 aktualne informacije"

Spain

General Pharmaceutical Council of Spain:

Turkey

COVID-19 (SARS-CoV-2 ENFEKSİYONU) REHBERİ

Turkish Pharmacists Association

"COVID-19 Hub"

UAE

Ministry of health and preventionGuide for coronavirus 

Uganda

Proposal on sustainable hand hygiene in low- and middle-income countries

United Kingdom

Academy of Pharmaceutical Sciences (APS): Coronavirus info

British Medical Journal – Best PracticeOverview of novel coronavirus (SARS-CoV-2)

Medicines & Healthcare products Regulatory Agency: Coronavirus (COVID-19): guidance and support

PhRMA (biopharmaceutical research companies): Member Company Efforts to Combat Coronavirus Outbreak

Royal Pharmaceutical Society: 

The Lancet: SARS-CoV-2 Resource Centre (open access)

The Pharmaceutical Journal: Everything you should know about the coronavirus outbreak

UK Government: How tests and testing kits for coronavirus (COVID-19) work

United Nations

UNESCO: 

WHO: 

 

Uruguay

Association of Chemistry and Pharmacy:

USA

American Pharmacists Association: "COVID-19 Practice Resources"

American Society of Health-System Pharmacists:

Centers for Disease Control and Prevention: 2019 novel coronavirus

Johns Hopkins University –Center for Systems Science and EngineeringSARS-CoV-2 Global Cases update

National Academy of Medicine: Coronavirus resources

National Institutes of Health: COVID-19 Treatment Guidelines

University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences & Colorado Pharmacists Society: "COVID-19: Implications for Pharmacists" (PowerPoint slides)

United States Pharmacopeia:

Wiley Scientific Publisher: Coronavirus research centre

Questions from FIP members and member organisations

End of life care

 

Articles & Other

 

 

FIP COVID-19 Timeline

 COVID19 Timeline 16 July

 

In memoriam

Pharmacy teams are risking their lives to continue to provide health care to their communities and support our health systems during this coronavirus pandemic. Inevitably, deaths of colleagues from COVID-19 are being reported to FIP from around the world.  With this list, we would like to make sure that none of these colleagues are forgotten.

Adriana Alia Gómez (Spain)
Camillo Alinovi (Italy)
Oscar J. Álvarez Rodríguez (Spain)
Teresa Baca Cruces (Spain)
Jayesh Bhanubhai Patel (UK)
Reanna Casalini (Italy)
Victor Chanda (Zambia)
Florentina Cimiano Valera (Spain)
Jaime Clavijo (Spain)
Raffaele Corbellini (Italy) 
María del Carmen Cuadrado (Spain)
Sean D.Boynes (USA)
Paolo D’Ambrogi (Italy)
Francesco De Donno (Italy) 
Santiago Díez García (Spain)
İsmail Durmuş (Turkey)
Plumarz K Ferzandi (India) 
Patrizio Forti Paolini (Italy) 
Amparo Gadea (Spain)
Pedro García  (Spain)
İhsan Giray (Turkey)
Julio Gutiérrez Montalvo (Spain)
Himmet Taştan Kardaşlar (Turkey) 
Fernando Marcantonio (Italy) 
Fermín Martínez (USA)
Abdelilah Mesfioui (Morocco)
José Tomás Mijimolle (Spain) 
Ekrem Özdemir (Pharmacy technician, Turkey)
Shashikant Parekh (UK)
Mehool Patel (UK)
Hilario Pellín (Spain)
Antonio Perani (Italy)
Nieves Quiralte Abello (Spain)
Birender Rawat (UK)
Michel Renson (Belgium)
Lorenzo Repetto (Italy)
Daniela Rigoni (Italy)
Manuel Ruiz (Spain)
Francisco Javier Santamaría Blanco (Spain)
Yves-Emmanuel Segui (USA)
Pooja Sharma (Hospital pharmacist, UK) 
Mandy Siddorn (Community pharmacy technician, UK) 
Süreyya Sıpkınkurt (Turkey) 
Yingjie Song (China) 
Navin Shantilal Talati (UK)
Antonio Tilli (Italy)
Taki Turkyilmaz (Turkey)
Merih Yalçınöz (Turkey) 
Yücel Yildirim (Turkey)
Jermaine Wright (UK) 
Luis (surname withheld) (Spain)
Pharmacist (name withheld) (Spain)
Pharmacist (name withheld) (Spain)
Pharmacist (name withheld) (Spain)
Pharmacist (name withheld) (Spain)

Last update 26 February 2021

FIP Congresses